887 related articles for article (PubMed ID: 25500544)
1. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
3. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
[TBL] [Abstract][Full Text] [Related]
4. RET fusion as a novel driver of medullary thyroid carcinoma.
Grubbs EG; Ng PK; Bui J; Busaidy NL; Chen K; Lee JE; Lu X; Lu H; Meric-Bernstam F; Mills GB; Palmer G; Perrier ND; Scott KL; Shaw KR; Waguespack SG; Williams MD; Yelensky R; Cote GJ
J Clin Endocrinol Metab; 2015 Mar; 100(3):788-93. PubMed ID: 25546157
[TBL] [Abstract][Full Text] [Related]
5. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Noncanonical RET Fusions in Non-Small-Cell Lung Cancer through DNA and RNA Sequencing.
Xiang C; Guo L; Zhao R; Teng H; Wang Y; Xiong L; Han Y
J Mol Diagn; 2022 Apr; 24(4):374-385. PubMed ID: 35063667
[TBL] [Abstract][Full Text] [Related]
7. The landscape of chimeric RNAs in bladder urothelial carcinoma.
Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H
Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082
[TBL] [Abstract][Full Text] [Related]
8. TumorFusions: an integrative resource for cancer-associated transcript fusions.
Hu X; Wang Q; Tang M; Barthel F; Amin S; Yoshihara K; Lang FM; Martinez-Ledesma E; Lee SH; Zheng S; Verhaak RGW
Nucleic Acids Res; 2018 Jan; 46(D1):D1144-D1149. PubMed ID: 29099951
[TBL] [Abstract][Full Text] [Related]
9. Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines.
Woodward EL; Biloglav A; Ravi N; Yang M; Ekblad L; Wennerberg J; Paulsson K
Endocr Relat Cancer; 2017 May; 24(5):209-220. PubMed ID: 28235956
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.
Shah N; Lankerovich M; Lee H; Yoon JG; Schroeder B; Foltz G
BMC Genomics; 2013 Nov; 14(1):818. PubMed ID: 24261984
[TBL] [Abstract][Full Text] [Related]
11. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract][Full Text] [Related]
13. An integrated analysis of cancer genes in thyroid cancer.
Chai L; Li J; Lv Z
Oncol Rep; 2016 Feb; 35(2):962-70. PubMed ID: 26718127
[TBL] [Abstract][Full Text] [Related]
14. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M
J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728
[TBL] [Abstract][Full Text] [Related]
15. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
Ross JS; Wang K; Chmielecki J; Gay L; Johnson A; Chudnovsky J; Yelensky R; Lipson D; Ali SM; Elvin JA; Vergilio JA; Roels S; Miller VA; Nakamura BN; Gray A; Wong MK; Stephens PJ
Int J Cancer; 2016 Feb; 138(4):881-90. PubMed ID: 26314551
[TBL] [Abstract][Full Text] [Related]
16. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
Hsiao SJ; Zehir A; Sireci AN; Aisner DL
J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
[TBL] [Abstract][Full Text] [Related]
17. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
[TBL] [Abstract][Full Text] [Related]
18. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
[TBL] [Abstract][Full Text] [Related]
19. Novel kinase fusion transcripts found in endometrial cancer.
Tamura R; Yoshihara K; Yamawaki K; Suda K; Ishiguro T; Adachi S; Okuda S; Inoue I; Verhaak RG; Enomoto T
Sci Rep; 2015 Dec; 5():18657. PubMed ID: 26689674
[TBL] [Abstract][Full Text] [Related]
20. Emerging Targeted Therapy for Tumors with
Kheder ES; Hong DS
Clin Cancer Res; 2018 Dec; 24(23):5807-5814. PubMed ID: 29986850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
